Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Immune Response Against Viral Pathogens

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...

Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

HDV sensing drives USP18-mediated refractoriness to IFN-α response, sparing IFN-β/λ in hepatocytes.

Antiviral research·2026

Same author

Hepatitis B virus-infected hepatocytes promote the secretion of collagen VI to the extracellular matrix.

Scientific reports·2025

Same author

Virology special issue: Hepatitis B.

Virology·2025

Same author

Clinical trials for Hepatitis Delta Virus in the WHO African region: A neglected virus among neglected viruses.

The Journal of infection·2025

Same author

A novel <i>in vitro</i> system for simultaneous infections with hepatitis B, C, D and E viruses.

JHEP reports : innovation in hepatology·2025

Same author

Hijacking JAKis: JAK inhibitors as potential antiviral molecules, a mini review.

Antiviral research·2025

Search research articles

Related Experiment Video

Updated: Mar 11, 2026

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Published on: October 20, 2021

The complex interplay between hepatitis D virus and the interferon response.

Claudie Eber¹, Eloi R Verrier²

¹Université de Strasbourg, Inserm, UMRS 1110, Institute for Translational Medicine and Liver Disease, Strasbourg, France.

Biomedical Journal

|March 9, 2026

Summary

Hepatitis D virus (HDV) infection causes severe hepatitis, with limited treatments. Understanding interferon resistance is key to developing better therapies for this global health challenge.

Keywords:

Hepatitis D virus Innate immunity Interferon Therapy

More Related Videos

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

Related Experiment Videos

Last Updated: Mar 11, 2026

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Published on: October 20, 2021

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

Area of Science:

Hepatology
Virology
Immunology

Background:

Hepatitis D virus (HDV) causes severe chronic hepatitis, leading to cirrhosis and liver cancer.
Limited therapeutic options exist, with pegylated interferon alpha (PEG-IFN-α) being widely used but having modest efficacy and side effects.

Purpose of the Study:

To review the mechanisms of interferon responsiveness and resistance in HDV infection.
To identify limitations and future directions for optimizing interferon-based therapies.

Main Methods:

Literature review synthesizing current knowledge on HDV-interferon interactions.
Discussion of experimental models used in HDV research.

Main Results:

HDV induces interferon responses, but these are insufficient for viral control.
Mechanisms of resistance include viral nuclear replication and interference with interferon signaling.

Conclusions:

Optimizing interferon-based and combination therapies requires a deeper understanding of HDV's interaction with the innate immune response.
Further research is needed to overcome interferon resistance and improve treatment outcomes for chronic hepatitis D.